George Eric Davis

CIK: 0001380710

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (64.3%)

Compensation grants

Other (G, F, J, C, D, …)3 (21.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BMRN

BIOMARIN PHARMACEUTICAL INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

BMRN
BIOMARIN PHARMACEUTICAL INC
Sep 2, 2026
Sale(S)
Direct
17.6K shares at avg. $66.28$1.2M
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 18, 2026
Tax Payment(F)
Direct
1.3K shares at avg. $56.05$71K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 16, 2026
Award(A)
Direct
14.6K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 16, 2026
Tax Payment(F)
Direct
7.2K shares at avg. $58.51$420K
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 26, 2026
Sale(S)
Direct
26.1K shares at avg. $61.36$1.6M
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 25, 2026
Award(A)
Direct
6.7K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 25, 2026
Award(A)
Direct
6.2K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 25, 2026
Award(A)
Direct
2.4K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Apr 30, 2025
Award(A)
Direct
375 shares at avg. $54.14$20K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2025
Award(A)
Direct
12.9K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 14, 2025
Tax Payment(F)
Direct
16.2K shares at avg. $69.44$1.1M
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 25, 2025
Award(A)
Direct
9.7K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 25, 2025
Award(A)
Direct
9.4K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 25, 2025
Award(A)
Direct
11K shares-

		Type	Shares	Price		Ownership
Sep 2, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Sale(S)	17,557	$66.28	$1,163,748	Direct
Mar 18, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	1,273	$56.05	$71,352	Direct
Mar 16, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	14,570	-	$0	Direct
Mar 16, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	7,177	$58.51	$419,926	Direct
Feb 26, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Sale(S)	26,061	$61.36	$1,599,103	Direct
Feb 25, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	6,675	-	$0	Direct
Feb 25, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	6,177	-	$0	Direct
Feb 25, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	2,372	-	$0	Direct
Apr 30, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	375	$54.14	$20,301	Direct
Mar 17, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	12,940	-	-	Direct
Mar 14, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	16,249	$69.44	$1,128,331	Direct
Feb 25, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	9,660	-	-	Direct
Feb 25, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	9,367	-	-	Direct
Feb 25, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	11,040	-	-	Direct

1-14 of 14 transactions

About Davis George Eric

Davis George Eric (SEC CIK 0001380710) files insider reports with the SEC as EVP, Chief Legal Officer of BIOMARIN PHARMACEUTICAL INC (BMRN).

Signal8 holds 7 ownership filings by Davis George Eric (6 Form 4, 1 Form 5), filed between Feb 27, 2025 and Sep 3, 2026. Those filings report 14 transactions, from Feb 25, 2025 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Davis George Eric's filings is in SAN RAFAEL, CA.

Recent filings by Davis George Eric

Sep 2, 2026: Open-market sale of BMRN shares (Form 4, code S).
Mar 18, 2026: Tax withholding of BMRN shares (Form 4, code F).
Mar 16, 2026: Grant or award of BMRN shares (Form 4, code A).
Mar 16, 2026: Tax withholding of BMRN shares (Form 4, code F).
Feb 26, 2026: Open-market sale of BMRN shares (Form 4, code S).

Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

Friberg Gregory R, EVP, Chief R&D Officer
Plenge Robert M, Director
Countouriotis Athena, Director
Walbert Timothy P, Director
Ho Maykin, Director
HOMBACH ROBERT J., Director

How to read Form 4 transaction codes